The HIV-1 group mepidemic in the Asia-Pacific

Exposure Therapy: New Developments

Volumn , Issue , 2012, Pages 246-271

  Oyomopito, Rebecca A ^a  

^a NPS: Better choices Better health   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84892913445     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (191)

1. A. B. Sabin, Br Med J 1, 663 (1959).
2. V. Courgnaud, F. Laure, P. N. Fultz, L. Montagnier, C. Brechot, P. Sonigo, J Virol 66, 414 (1992).
3. A. J. Garrett, A. Dunham, D. J. Wood, Lancet 342, 932 (1993).
4. B. F. Elswood, R. B. Stricker, Med Hypotheses 42, 347 (1994).
5. E. Hooper, The River: A Journey to the Source of HIV and AIDS.(1999).
6. A. Rambaut, D. L. Robertson, O. G. Pybus, M. Peeters, E. C. Holmes, Nature 410, 1047 (2001).
7. M. Worobey, M. Gemmel, D. E. Teuwen, T. Haselkorn, K. Kunstman, M. Bunce, J. J. Muyembe, J. M. Kabongo et al., Nature 455, 661 (2008).
8. J. D. de Sousa, V. Muller, P. Lemey, A. M. Vandamme, PLoS One 5, e9936 (2010).
9. T. Zhu, B. T. Korber, A. J. Nahmias, E. Hooper, P. M. Sharp, D. D. Ho, Nature 391, 594 (1998).
10. M. Alizon, L. Montagnier, Ann N Y Acad Sci 511, 376 (1987).
11. D. Posada, Curr Protoc Bioinformatics Chapter 6, Unit 6 5 (2003).
12. Z. Yang, Mol Biol Evol 24, 1586 (2007).
13. M. Salemi, A.-M. Vandamme, P. Lemey, The phylogenetic handbook: a practical approach to phylogenetic analysis and hypothesis testing.(Cambridge University Press, Cambridge, UK; New York, ed. 2nd, 2009), pp. xxvi, 723 p.
14. D. L. Robertson, J. P. Anderson, J. A. Bradac, J. K. Carr, B. Foley, R. K. Funkhouser, F. Gao, B. H. Hahn et al., Science 288, 55 (2000).
15. J. C. Plantier, M. Leoz, J. E. Dickerson, F. De Oliveira, F. Cordonnier, V. Lemee, F. Damond, D. L. Robertson et al., Nat Med 15, 871 (2009).
16. A. Vallari, V. Holzmayer, B. Harris, J. Yamaguchi, C. Ngansop, F. Makamche, D. Mbanya, L. Kaptue et al., J Virol 85, 1403 (2011).
17. F. Gao, E. Bailes, D. L. Robertson, Y. Chen, C. M. Rodenburg, S. F. Michael, L. B. Cummins, L. O. Arthur et al., Nature 397, 436 (1999).
18. B. F. Keele, F. Van Heuverswyn, Y. Li, E. Bailes, J. Takehisa, M. L. Santiago, F. Bibollet-Ruche, Y. Chen et al., Science 313, 523 (2006).
19. M. Peeters, M. L. Chaix, E. Delaporte, Med Sci (Paris) 24, 621 (2008).
20. J. Takehisa, M. H. Kraus, A. Ayouba, E. Bailes, F. Van Heuverswyn, J. M. Decker, Y. Li, R. S. Rudicell et al., J Virol 83, 1635 (2009).
21. P. M. Sharp, E. Bailes, D. L. Robertson, F. Gao, B. H. Hahn, Biol Bull 196, 338 (1999).
22. M. L. Santiago, F. Range, B. F. Keele, Y. Li, E. Bailes, F. Bibollet-Ruche, C. Fruteau, R. Noe et al., J Virol 79, 12515 (2005).
23. T. I. de Silva, M. Cotten, S. L. Rowland-Jones, Trends Microbiol 16, 588 (2008).
24. B. S. Taylor, M. E. Sobieszczyk, F. E. McCutchan, S. M. Hammer, N Engl J Med 358, 1590 (2008).
25. CDC, MMWR Morb Mortal Wkly Rep 30, 305 (1981)
26. M. S. Gottlieb, R. Schroff, H. M. Schanker, J. D. Weisman, P. T. Fan, R. A. Wolf, A. Saxon, N Engl J Med 305, 1425 (1981).
27. F. Barre-Sinoussi, J. C. Chermann, F. Rey, M. T. Nugeyre, S. Chamaret, J. Gruest, C. Dauguet, C. Axler-Blin et al., Science 220, 868 (1983).
28. C. Rouzioux, Rev Prat 41, 324 (1991).
29. J. M. Albert, J. P. Ioannidis, P. Reichelderfer, B. Conway, R. W. Coombs, L. Crane, R. Demasi, D. O. Dixon et al., Stat Med 17, 2435 (1998).
30. B. Korber, B. T. Foley, C. Kuiken, S. K. Pillai andJ. G. Sodroski, Numbering Positions in HIV Relative to HXB2CG, in Human Retroviruses and AIDS, pp. III-102-111 (Eds) B. Korber, C. L. Kuiken, B. Foley, B. Hahn, F. McCutchan, J. W. Mellors and J. Sodroski. Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM.,(1998).
31. S. Y. Rhee, M. J. Gonzales, R. Kantor, B. J. Betts, J. Ravela, R. W. Shafer, Nucleic acids research 31, 298 (2003).
32. T. T. Lam, C. C. Hon, J. W. Tang, Crit Rev Clin Lab Sci 47, 5 (2010).
33. A. von Bubnoff, IAVI Report 14,(2010).
34. UNAIDS, "Annual Report: uniting the world against AIDS"(2009)
35. UNAIDS, "AIDS epidemic update"(2009)
36. WHO, "Global report: UNAIDS report on the global AIDS epidemic"(2010)
37. WHO, "World Health Statistics"(2008)
38. UNAIDS, "A framework for monitoring and evaluating HIV preventionprogrammes for most-at-risk populations"(2008)
39. WHO, "Towards universal access: scaling up priority HIV/AIDS interventions in the health sector: progress report."(2009).
40. UNESCAP. ESCAP Population Data Sheet.(2009), accessed 03 May 2010, at: www.unescap.org.
41. UNFPA, "The state of world population 2009"(United Nations Population Fund,2009)
42. K. Ruxrungtham, T. Brown, P. Phanuphak, Lancet 364, 69 (2004).
43. WHO Western Pacific Region, "Consultation on the strengthening of the World Health Organization Network for HIV and Health in the Western Pacific Region"(2009)
44. SEARO, "HIV/AIDS in the South-East Asia Region "(2009)
45. UNAIDS. UNGASS progress reports submitted by countries.(2010), accessed 02 November 2010, at: http://www.unaids.org/en/KnowledgeCentre/HIVDataCountryProgress/2010CountryProgressAllCountries.asp.
46. Commission on AIDS in Asia. (Oxford University Press, New Delhi, 2008).
47. UN General Assembly. Progress made in the implementation of the Declaration of Commitment on HIV/AIDS and the Political Declaration on HIV/AIDS: report of the Secretary-General, 1 April 2010, A/64/735.(2010), accessed accessed 14 July 2010, at: http://www.unhcr.org/refworld/docid/4bfce2992.html.
48. WHO, "Towards universal access: scaling up priority HIV/AIDS interventions in the health sector: progress report"(2010)
49. AUSAID, "Impacts of HIV/AIDS 2005-2025 in Papua New Guinea, Indonesia and East Timor"(2006)
50. ASEAN. Treatment and Care for HIV-Positive Injecting Drug Users. The Association of Southeast Asian Nations; (2007),updated 03 May 2010 accessed, at: www.aseansec.org.
51. SEARO, "HIV/AIDS in the South-East Asia Region: progress report"(2010)
52. M. C. Nariddh, Aidscaptions 1, 20 (1994).
53. UNAIDS, "Epidemiological Fact Sheets on HIV/AIDS and Sexually Transmitted Infections China"(2002)
54. UNAIDS. UNGASS progress reports submitted by countries.(2008), accessed 02 November 2010, at: http://www.unaids.org/en/KnowledgeCentre/HIVData/CountryProgress/2007CountryProgressAllCountries.asp.
55. Secretariat of the Pacific Community, "The Pacific Regional Strategy On HIV/AIDS"(2005)
56. UNAIDS, "Epidemiological Fact Sheets on HIV/AIDS and Sexually Transmitted Infections Australia"(2004)
57. UNAIDS, "Epidemiological Fact Sheets on HIV/AIDS and Sexually Transmitted Infections New Zealand"(2004)
58. [AIDSInfo [online database] (2010). Available from: http://www.aidsinfoonline.org/.
59. WHO, "Priority HIV and sexual health interventions in the health sector for men who have sex with men and transgender people in the Asia-Pacific Region"(2010)
60. UNPF, "HIV Prevention for Girls and Young Women Report Cards"(United Nations Population Fund,2010)
61. M. S. Cohen, N. Hellmann, J. A. Levy, K. DeCock, J. Lange, J Clin Invest 118, 1244 (2008).
62. A. G. Dalgleish, P. C. Beverley, P. R. Clapham, D. H. Crawford, M. F. Greaves, R. A. Weiss, Nature 312, 763 (1984).
63. F. Krebs, Hogan TH., Quiterio S., Gartner S., Wigdahl B., in HIV Sequence Compendium 2001 F. B. Kuiken C, Hahn B, Marx P, McCutchan F, Mellors JW, Wolinsky S, Korber B., Ed. (Theoretical Biology and Biophysics Group, Los Alamos National Laboratory,, Los Alamos, NM, LA-UR 02-2877, 2001),pp. pp. 29-70.
64. G. Pantaleo, C. Graziosi, A. S. Fauci, N Engl J Med 328, 327 (1993).
65. D. A. Cooper, J. Gold, P. Maclean, B. Donovan, R. Finlayson, T. G. Barnes, H. M. Michelmore, P. Brooke et al., Lancet 1, 537 (1985).
66. B. Tindall, D. A. Cooper, AIDS (London, England) 5, 1 (1991).
67. R. Brookmeyer, Science 253, 37 (1991).
68. S. G. Deeks, C. M. Kitchen, L. Liu, H. Guo, R. Gascon, A. B. Narvaez, P. Hunt, J. N. Martin et al., Blood 104, 942 (2004).
69. A. S. Fauci, G. Pantaleo, S. Stanley, D. Weissman, Annals of internal medicine 124, 654 (1996).
70. CDC, MMWR Recomm Rep 57, 1 (2008)
71. DHHS, D. o. H. a. H. Services, Ed. (2011).
72. Y. Cao, L. Qin, L. Zhang, J. Safrit, D. D. Ho, N Engl J Med 332, 201 (1995).
73. A. Munoz, A. J. Kirby, Y. D. He, J. B. Margolick, B. R. Visscher, C. R. Rinaldo, R. A. Kaslow, J. P. Phair, J Acquir Immune Defic Syndr Hum Retrovirol 8, 496 (1995).
74. G. Pantaleo, S. Menzo, M. Vaccarezza, C. Graziosi, O. J. Cohen, J. F. Demarest, D. Montefiori, J. M. Orenstein et al., N Engl J Med 332, 209 (1995).
75. J. B. Hubert, M. Burgard, E. Dussaix, C. Tamalet, C. Deveau, J. Le Chenadec, M. L. Chaix, E. Marchadier et al., AIDS (London, England) 14, 123 (2000).
76. S. G. Deeks, B. D. Walker, Immunity 27, 406 (2007).
77. J. N. Blankson, J. R. Bailey, S. Thayil, H. C. Yang, K. Lassen, J. Lai, S. K. Gandhi, J. D. Siliciano et al., J Virol 81, 2508 (2007).
78. T. C. Quinn, M. J. Wawer, N. Sewankambo, D. Serwadda, C. Li, F. Wabwire-Mangen, M. O. Meehan, T. Lutalo et al., N Engl J Med 342, 921 (2000).
79. M. J. Wawer, R. H. Gray, N. K. Sewankambo, D. Serwadda, X. Li, O. Laeyendecker, N. Kiwanuka, G. Kigozi et al., J Infect Dis 191, 1403 (2005).
80. R. H. Gray, M. J. Wawer, R. Brookmeyer, N. K. Sewankambo, D. Serwadda, F. Wabwire-Mangen, T. Lutalo, X. Li et al., Lancet 357, 1149 (2001).
81. T. D. Hollingsworth, R. M. Anderson, C. Fraser, J Infect Dis 198, 687 (2008).
82. D. K. Clarke, E. A. Duarte, A. Moya, S. F. Elena, E. Domingo, J. Holland, J Virol 67, 222 (1993).
83. K. J. Bar, H. Li, A. Chamberland, C. Tremblay, J. P. Routy, T. Grayson, C. Sun, S. Wang et al., J Virol 84, 6241 (2010).
84. B. F. Keele, E. E. Giorgi, J. F. Salazar-Gonzalez, J. M. Decker, K. T. Pham, M. G. Salazar, C. Sun, T. Grayson et al., Proceedings of the National Academy of Sciences of the United States of America 105, 7552 (2008).
85. M. R. Abrahams, J. A. Anderson, E. E. Giorgi, C. Seoighe, K. Mlisana, L. H. Ping, G. S. Athreya, F. K. Treurnicht et al., J Virol 83, 3556 (2009).
86. R. E. Haaland, P. A. Hawkins, J. Salazar-Gonzalez, A. Johnson, A. Tichacek, E. Karita, O. Manigart, J. Mulenga et al., PLoS Pathog 5, e1000274 (2009).
87. G. S. Gottlieb, D. C. Nickle, M. A. Jensen, K. G. Wong, J. Grobler, F. Li, S. L. Liu, C. Rademeyer et al., Lancet 363, 619 (2004).
88. O. Dosekun, J. Fox, Curr Opin HIV AIDS 5, 291 (2010).
89. S. R. Galvin, M. S. Cohen, Nat Rev Microbiol 2, 33 (2004).
90. E. M. Connor, R. S. Sperling, R. Gelber, P. Kiselev, G. Scott, M. J. O'Sullivan, R. VanDyke, M. Bey et al., N Engl J Med 331, 1173 (1994).
91. F. Dabis, L. Bequet, D. K. Ekouevi, I. Viho, F. Rouet, A. Horo, C. Sakarovitch, R. Becquet et al., AIDS (London, England) 19, 309 (2005).
92. WHO. Frequently asked questions about TB and HIV.(2010), accessed 20 May 2010, at: http://www.who.int/tb/challenges/hiv/faq/en/index.html.
93. S. D. Lawn, R. J. Wilkinson, M. C. Lipman, R. Wood, Am J Respir Crit Care Med 177, 680 (2008).
94. WHO, "Global tuberculosis control: a short update to the 2009 report."(2009).
95. WHO. Hepatitis.(2010), accessed 20 May 2010, at: http://www.who.int/topics/hepatitis/en/.
96. V. Soriano, E. Vispo, P. Labarga, J. Medrano, P. Barreiro, Antiviral Res 85, 303 (2010).
97. M. J. Alter, J Hepatol 44, S6 (2006).
98. M. S. Sulkowski, D. L. Thomas, R. E. Chaisson, R. D. Moore, JAMA 283, 74 (2000).
99. G. Greub, B. Ledergerber, M. Battegay, P. Grob, L. Perrin, H. Furrer, P. Burgisser, P. Erb et al., Lancet 356, 1800 (2000).
100. R. Oyomopito, M. P. Lee, P. Phanuphak, P. L. Lim, R. Ditangco, J. Zhou, T. Sirisanthana, Y. M. Chen et al., HIV Med, (2010).
101. J. Chinen, W. T. Shearer, J Allergy Clin Immunol 110, 189 (2002).
102. J. Stebbing, B. Gazzard, D. C. Douek, N Engl J Med 350, 1872 (2004).
103. J. M. Coffin, Science 267, 483 (1995).
104. J. Chinen, W. T. Shearer, J Allergy Clin Immunol 121, S388 (2008).
105. M. D. Hughes, Controlled Clinical Trials 23, 703 (2002).
106. Z. Zhang, T. Schuler, M. Zupancic, S. Wietgrefe, K. A. Staskus, K. A. Reimann, T. A. Reinhart, M. Rogan et al., Science 286, 1353 (1999).
107. D. Finzi, M. Hermankova, T. Pierson, L. M. Carruth, C. Buck, R. E. Chaisson, T. C. Quinn, K. Chadwick et al., Science 278, 1295 (1997).
108. T. Pierson, J. McArthur, R. F. Siliciano, Annu Rev Immunol 18, 665 (2000).
109. A. S. Perelson, P. Essunger, Y. Cao, M. Vesanen, A. Hurley, K. Saksela, M. Markowitz, D. D. Ho, Nature 387, 188 (1997).
110. G. Pantaleo, C. Graziosi, L. Butini, P. A. Pizzo, S. M. Schnittman, D. P. Kotler, A. S. Fauci, Proceedings of the National Academy of Sciences of the United States of America 88, 9838 (1991).
111. F. T. Hufert, J. van Lunzen, G. Janossy, S. Bertram, J. Schmitz, O. Haller, P. Racz, D. von Laer, AIDS (London, England) 11, 849 (1997).
112. J. Embretson, M. Zupancic, J. L. Ribas, A. Burke, P. Racz, K. Tenner-Racz, A. T. Haase, Nature 362, 359 (1993).
113. J. N. Blankson, D. Persaud, R. F. Siliciano, Annu Rev Med 53, 557 (2002).
114. US Department of Health and Human Services, "Martin Delaney Collaboratory:Towards an HIV-1 Cure (U19)- RFA Number:RFA-AI-10-009"(2010)
115. J. D. Barbour, R. M. Grant, Curr HIV/AIDS Rep 2, 29 (2005).
116. A. D. Frankel, J. A. Young, Annu Rev Biochem 67, 1 (1998).
117. B. Alberts, Molecular biology of the cell.(Garland Science, New York, ed. 5th, 2008).
118. S. P. Goff, Nat Rev Microbiol 5, 253 (2007).
119. A. L. Brass, D. M. Dykxhoorn, Y. Benita, N. Yan, A. Engelman, R. J. Xavier, J. Lieberman, S. J. Elledge, Science 319, 921 (2008).
120. M. Zhang, B. Foley, A. K. Schultz, J. P. Macke, I. Bulla, M. Stanke, B. Morgenstern, B. Korber et al., Retrovirology 7, 25 (2010).
121. R. W. Doms, J. P. Moore, J Cell Biol 151, F9 (2000).
122. J. Weber, F. Grosse, Nucleic acids research 17, 1379 (1989).
123. M. Sala, S. Wain-Hobson, F. Schaeffer, EMBO J 14, 4622 (1995).
124. A. Marchler-Bauer, J. B. Anderson, F. Chitsaz, M. K. Derbyshire, C. DeWeese-Scott, J. H. Fong, L. Y. Geer, R. C. Geer et al., Nucleic acids research 37, D205 (2009).
125. M. Parera, N. Perez-Alvarez, B. Clotet, M. A. Martinez, J Mol Biol 392, 243 (2009).
126. J. Zhuang, A. E. Jetzt, G. Sun, H. Yu, G. Klarmann, Y. Ron, B. D. Preston, J. P. Dougherty, J Virol 76, 11273 (2002).
127. D. N. Levy, G. M. Aldrovandi, O. Kutsch, G. M. Shaw, Proceedings of the National Academy of Sciences of the United States of America 101, 4204 (2004).
128. W. S. Hu, H. M. Temin, Proceedings of the National Academy of Sciences of the United States of America 87, 1556 (1990).
129. B. C. Ramirez, E. Simon-Loriere, R. Galetto, M. Negroni, Virus Res 134, 64 (2008).
130. D. J. McColl, X. Chen, Antiviral Res 85, 101 (2010).
131. C. Peng, B. K. Ho, T. W. Chang, N. T. Chang, J Virol 63, 2550 (1989).
132. N. E. Kohl, E. A. Emini, W. A. Schleif, L. J. Davis, J. C. Heimbach, R. A. Dixon, E. M. Scolnick, I. S. Sigal, Proceedings of the National Academy of Sciences of the United States of America 85, 4686 (1988).
133. R. S. Harris, M. T. Liddament, Nat Rev Immunol 4, 868 (2004).
134. P. Jern, R. A. Russell, V. K. Pathak, J. M. Coffin, PLoS Pathog 5, e1000367 (2009).
135. E. Domingo, J. J. Holland, P. Ahlquist, RNA genetics.(CRC Press, Boca Raton, Fla., 1988).
136. B. Korber, B. Gaschen, K. Yusim, R. Thakallapally, C. Kesmir, V. Detours, Br Med Bull 58, 19 (2001).
137. C. Briones, E. Domingo, AIDS reviews 10, 93 (2008).
138. Y. Mitsuya, V. Varghese, C. Wang, T. F. Liu, S. P. Holmes, P. Jayakumar, B. Gharizadeh, M. Ronaghi et al., J Virol 82, 10747 (2008).
139. J. Hemelaar, E. Gouws, P. D. Ghys, S. Osmanov, AIDS (London, England) 20, W13 (2006).
140. S. Guindon, O. Gascuel, Syst Biol 52, 696 (2003).
141. J. K. Carr, M. O. Salminen, C. Koch, D. Gotte, A. W. Artenstein, P. A. Hegerich, D. St Louis, D. S. Burke et al., J Virol 70, 5935 (1996).
142. Los Alamos National Laboratory. HIV Circulating Recombinant Forms (CRFs).(2010), accessed 05 January 2011, at: http://www.hiv.lanl.gov/content/sequence/HIV/CRFs/CRFs.html.
143. F. Gao, D. L. Robertson, C. D. Carruthers, S. G. Morrison, B. Jian, Y. Chen, F. Barre-Sinoussi, M. Girard et al., J Virol 72, 5680 (1998).
144. L. H. Ping, J. A. Nelson, I. F. Hoffman, J. Schock, S. L. Lamers, M. Goodman, P. Vernazza, P. Kazembe et al., J Virol 73, 6271 (1999).
145. R. I. Connor, K. E. Sheridan, D. Ceradini, S. Choe, N. R. Landau, J Exp Med 185, 621 (1997).
146. C. Tscherning, A. Alaeus, R. Fredriksson, A. Bjorndal, H. Deng, D. R. Littman, E. M. Fenyo, J. Albert, Virology 241, 181 (1998).
147. P. Kaleebu, N. French, C. Mahe, D. Yirrell, C. Watera, F. Lyagoba, J. Nakiyingi, A. Rutebemberwa et al., J Infect Dis 185, 1244 (2002).
148. N. Kiwanuka, O. Laeyendecker, T. C. Quinn, M. J. Wawer, J. Shepherd, M. Robb, G. Kigozi, J. Kagaayi et al., AIDS (London, England) 23, 2479 (2009).
149. R. L. Hamers, R. Oyomopito, C. Kityo, P. Phanuphak, M. Siwale, S. Sungkanuparph, F. Conradie, N. Kumarasamy et al., International journal of epidemiology,(2010).
150. US Food and Drug Administration. HIV/AIDS Historical Time Line 1981-1990.(2011); cited 2011 accessed 11 January 2011, at: http://www.fda.gov/.
151. US Food and Drug Administration. Antiretroviral drugs used in the treatment of HIV infection.(2011), accessed 11 January 2011, at: http://www.fda.gov/ForConsumers/byAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm118915.htm.
152. M. D. Hughes, V. A. Johnson, M. S. Hirsch, J. W. Bremer, T. Elbeik, A. Erice, D. R. Kuritzkes, W. A. Scott et al., Annals of internal medicine 126, 929 (1997).
153. G. K. Robbins, V. De Gruttola, R. W. Shafer, L. M. Smeaton, S. W. Snyder, C. Pettinelli, M. P. Dube, M. A. Fischl et al., N Engl J Med 349, 2293 (2003).
154. R. W. Shafer, L. M. Smeaton, G. K. Robbins, V. De Gruttola, S. W. Snyder, R. T. D'Aquila, V. A. Johnson, G. D. Morse et al., N Engl J Med 349, 2304 (2003).
155. T. Cihlar, A. S. Ray, Antiviral Res 85, 39 (2010).
156. M. P. de Bethune, Antiviral Res 85, 75 (2010).
157. A. M. Wensing, N. M. van Maarseveen, M. Nijhuis, Antiviral Res 85, 59 (2010).
158. WHO, "Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach."(2010).
159. M. Egger, M. May, G. Chene, A. N. Phillips, B. Ledergerber, F. Dabis, D. Costagliola, A. D'Arminio Monforte et al., Lancet 360, 119 (2002).
160. P. Braitstein, M. W. Brinkhof, F. Dabis, M. Schechter, A. Boulle, P. Miotti, R. Wood, C. Laurent et al., Lancet 367, 817 (2006).
161. UCSF Center for HIV Information. HIV InSite - Database of Antiretroviral Drug Interactions.(2011), accessed 17 January 2011, at: http://hivinsite.ucsf.edu/InSite.
162. M. Fantoni, C. Del Borgo, C. Autore, AIDS (London, England) 17 Suppl 1, S162 (2003).
163. T. Hawkins, Antiviral Res 85, 201 (2010).
164. EACS. (European AIDS Clinical Society 2010),pp. 1-10.
165. P. Mugyenyi, A. S. Walker, J. Hakim, P. Munderi, D. M. Gibb, C. Kityo, A. Reid, H. Grosskurth et al., Lancet 375, 123 (2010).
166. O. Keiser, H. Tweya, A. Boulle, P. Braitstein, M. Schecter, M. W. Brinkhof, F. Dabis, S. Tuboi et al., AIDS (London, England) 23, 1867 (2009).
167. A. Cozzi-Lepri, A. N. Phillips, L. Ruiz, B. Clotet, C. Loveday, J. Kjaer, H. Mens, N. Clumeck et al., AIDS (London, England) 21, 721 (2007).
168. K. Ariyoshi, M. Matsuda, H. Miura, S. Tateishi, K. Yamada, W. Sugiura, Journal of acquired immune deficiency syndromes (1999) 33, 336 (2003).
169. S. G. Deeks, R. M. Grant, T. Wrin, E. E. Paxinos, T. Liegler, R. Hoh, J. N. Martin, C. J. Petropoulos, AIDS (London, England) 17, 361 (2003).
170. S. H. Yap, C. W. Sheen, J. Fahey, M. Zanin, D. Tyssen, V. D. Lima, B. Wynhoven, M. Kuiper et al., PLoS medicine 4, e335 (2007).
171. V. A. Johnson, F. Brun-Vezinet, B. Clotet, H. F. Gunthard, D. R. Kuritzkes, D. Pillay, J. M. Schapiro, D. D. Richman, Top HIV Med 18, 156 (2010).
172. S. J. Little, S. Holte, J. P. Routy, E. S. Daar, M. Markowitz, A. C. Collier, R. A. Koup, J. W. Mellors et al., N Engl J Med 347, 385 (2002).
173. C. B. Perno, A., A. M. Geretti, Ed. (Mediscript, London, 2006).
174. D. K. Shafer RW, Winters MA, Eshleman SH, in Los Alamos National Laboratories; Los Alamos, NM: 2000. (2001).
175. A. D. Luber, J Int AIDS Soc 7, 69 (2005).
176. S. D. Frost, M. Nijhuis, R. Schuurman, C. A. Boucher, A. J. Brown, J Virol 74, 6262 (2000).
177. R. W. Shafer, J. M. Schapiro, AIDS reviews 10, 67 (2008).
178. U. M. Parikh, S. Zelina, N. Sluis-Cremer, J. W. Mellors, AIDS (London, England) 21, 1405 (2007).
179. D. E. Bennett, R. J. Camacho, D. Otelea, D. R. Kuritzkes, H. Fleury, M. Kiuchi, W. Heneine, R. Kantor et al., PLoS One 4, e4724 (2009).
180. T. F. Liu, R. W. Shafer, Clin Infect Dis 42, 1608 (2006).
181. S. Sungkanuparph, R. Oyomopito, S. Sirivichayakul, T. Sirisanthana, P. C. Li, P. Kantipong, C. K. Lee, A. Kamarulzaman et al., Clin Infect Dis 52, 1053 (2011).
182. J. L. Martinez-Cajas, N. Pant-Pai, M. B. Klein, M. A. Wainberg, AIDS reviews 10, 212 (2008).
183. A. Holguin, A. Alvarez, V. Soriano, AIDS (London, England) 16, 1163 (2002).
184. J. L. Martinez-Cajas, N. P. Pai, M. B. Klein, M. A. Wainberg, J Int AIDS Soc 12, 11 (2009).
185. B. G. Brenner, M. Oliveira, F. Doualla-Bell, D. D. Moisi, M. Ntemgwa, F. Frankel, M. Essex, M. A. Wainberg, AIDS (London, England) 20, F9 (2006).
186. B. Foley, H. Pan, S. Buchbinder, E. L. Delwart, AIDS Res Hum Retroviruses 16, 1463 (2000).
187. S. Sungkanuparph, W. Manosuthi, S. Kiertiburanakul, B. Piyavong, N. Chumpathat, W. Chantratita, Clin Infect Dis 44, 447 (2007).
188. Z. Woodman, C. Williamson, Curr Opin HIV AIDS 4, 247 (2009).
189. J. T. Parsons, J. Severino, J. Nanin, J. C. Punzalan, K. von Sternberg, W. Missildine, D. Frost, AIDS Educ Prev 18, 139 (2006).
190. K. J. Heymer, D. P. Wilson, AIDS24,(2010).
191. B. Brenner, D. Turner, M. Oliveira, D. Moisi, M. Detorio, M. Carobene, R. G. Marlink, J. Schapiro et al., AIDS (London, England) 17, F1 (2003).